Mucormycosis outbreak caused by Rhizomucor pusillus in a Hematopoietic Stem Cell Transplant Unit, Brazil

Clicks: 21
ID: 330808
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #153 of 180 articles by views in medical mycology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 180 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Mucormycosis is a severe fungal infection with high mortality in immunocompromised patients. Although most cases occur sporadically in the community setting, there are reports of healthcare associated outbreaks of mucormycosis. We describe the investigation and clinical features of an outbreak of mucormycosis caused by Rhizomucor pusillus in a hematopoietic stem cell transplant (HSCT) unit in Brazil. Cases were screened through the hospital records, defined according to the EORTC/MSGERC criteria, and classified as HSCT unit-acquired or not. Mucormycosis incidence was monitored from two years before the index case until two years after the last case. The clinical course of identified cases and potential environmental exposure data were recorded. Microbiological samples were identified with conventional methods and ITS sequencing; WGS was performed for phylogenetic analysis. Potential source investigation was conducted according to the US CDC recommendations. Four proven cases of HSCT-unit acquired mucormycosis were identified over a ten month period. Rhizomucor pusillus was identified in three of the four patients. Disseminated disease, beginning with pulmonary infection, was the most common clinical presentation. Survivors (75%) received treatment with lipid complex amphotericin B, isavuconazole, and/or surgical resection. Environmental investigation was negative and phylogenetic analysis demonstrated that isolates were not clonal. Following air system maintenance, no further cases were identified. We characterize the first reported outbreak investigation of mucormycosis caused by R. pusillus in a brazilian HSCT unit, with favorable outcome in most cases despite aggressive clinical presentation. Despite the lack of clonality and negative environmental investigation, epidemiological evidence strongly suggests nosocomial transmission.
Reference Key
openalex_W7215104929 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Giovanni Luís Breda, Regielly Caroline Raimundo Cognialli, Bram Spruijtenburg, Eelco F. J. Meijer, Graziela Cristina Buzutti Canova, Vânia Aparecida Vicente, Rafaella Muratori, Gisele Loth, Samir Kanaan Nabhan, Vaneuza Araújo Moreira Funke, Flávio Queiroz‐Telles
Journal medical mycology
Year 2026
DOI
10.1093/mmy/myag107
URL
https://doi.org/10.1093/mmy/myag107
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.